TMB-001

· Timber Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TMB-001, covering 2022-08-25 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis [Phase 3]